Serge T.
- Country
- France
- Department
- Service de Neurologie
Research Overview
- Tenecteplase plus Thrombectomy versus Thrombectomy Alone in Patients with Large Core Ischemic Stroke: A Multicentre Randomized Controlled Trial
- Efficacy of Apixaban Versus Standard Care in Patients with Intracerebral Hemorrhage: A Randomized Controlled Trial
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Asundexian for Ischemic Stroke Prevention in Adults Post-Acute Non-Cardioembolic Stroke or High-Risk TIA
Data & Insights
Has run more than one trial at 34 of 301 partner sites.
Specializations
Cerebrovascular Disorders
This investigator specializes in the management of intracerebral hemorrhage and its complications, with particular focus on anticoagulation strategies and preventive interventions.
- Hemorrhagic Stroke Management
- Anticoagulation Protocols
- Left Atrial Appendage Closure
Their research extends to evaluating therapeutic approaches for reducing mortality and improving patient outcomes following cerebral hemorrhage.
Cardiovascular Medicine
The investigator focuses on treating major vascular events and atherosclerotic conditions, including comprehensive management of various cardiac and cerebrovascular disorders.
- Ischemic Stroke Treatment
- Coronary Syndromes
- Antiplatelet Therapy
Their work encompasses therapeutic interventions for both acute and chronic cardiovascular conditions.
Stroke Prevention
Research interests include non-cardioembolic ischemic stroke prevention and treatment strategies, with emphasis on novel therapeutic approaches for patients with high-risk conditions.
- Transient Ischemic Attack Management
- Antithrombotic Therapy
- Secondary Stroke Prevention
The investigator evaluates innovative treatments for reducing recurrent stroke risk in vulnerable populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.